1. Taiwan Diabetes Care Devices Market Outlook to 2017-
Glucose Monitoring and Insulin Delivery
Report Details:
Published:December 2011
No. of Pages: 91
Price: Single User License – US$2500
Corporate User License – US$7500
Report Summary
GlobalData’s new report, Taiwan Diabetes Care Devices Market Outlook to 2017- Glucose
Monitoring and Insulin Delivery provides key market data on the Taiwan Diabetes Care Devices
market. The report provides value (USD million), volume (units) and average price (USD) data for
each segment and sub-segment within two market categories – Glucose Monitoring and Insulin
Delivery. The report also provides company shares and distribution shares data for each of the
aforementioned market categories. The report is supplemented with global corporate-level profiles
of the key market participants with information on company financials and pipeline products,
wherever available.
This report is built using data and information sourced from proprietary databases, primary and
secondary research and in-house analysis by GlobalData’s team of industry experts.
Scope
• Market size and company share data for Diabetes Care Devices market categories – Glucose
Monitoring and Insulin Delivery.
• Annualized market revenues (USD million), volume (units) and average price (USD) data for
each of the segments and sub-segments within two market categories. Data from 2003 to 2010,
forecast forward for 7 years to 2017.
• 2010 company shares and distribution shares data for each of the two market categories.
• Global corporate-level profiles of key companies operating within the Taiwan Diabetes Care
Devicesmarket.
• Key players covered include F. Hoffmann-La Roche Ltd., Novo Nordisk A/S, LifeScan, Inc.,
Sanofi, Eli Lilly and Company, TaiDoc Technology Corporation and others.
Reasons to buy
• Develop business strategies by identifying the key market categories and segments poised for
strong growth.
• Develop market-entry and market expansion strategies.
• Design competition strategies by identifying who-stands-where in the Taiwan Diabetes Care
Devices competitive landscape.

2. • Develop capital investment strategies by identifying the key market segments expected to
register strong growth in the near future.
• What are the key distribution channels and what’s the most preferred mode of product
distribution – Identify, understand and capitalize.
Get your copy of this report @
http://www.reportsnreports.com/reports/144210-taiwan-diabetes-care-devices-market-outlook-to-2017-glucose-
monitoring-and-insulin-delivery.html
Major points covered in Table of Contents of this report include
Table of Contents
1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 7
2 Introduction 9
2.1 What is This Report About? 9
3 Diabetes Care Devices In Taiwan 10
3.1 Diabetes Care Devices, Market Segmentation 10
3.2 Diabetes Care Devices, Taiwan, Overall Revenue ($m), USD Actual, 2003-2017 11
3.3 Diabetes Care Devices Market, Taiwan, Revenue Mix ($m), 2010 12
3.4 Diabetes Care Devices Market, Taiwan, Category Contribution (%), 2010 13
3.5 Diabetes Care Devices, Taiwan, Category Volume (Units), 2003-2017 20
3.6 Diabetes Care Devices, Taiwan, Company share (2009-2010) 23
4 Glucose Monitoring In Taiwan 25
4.1 Glucose Monitoring, Market Segmentation 25
4.2 Glucose Monitoring Market, Taiwan, Revenue Mix ($m), 2010 26
4.3 Glucose Monitoring Market, Taiwan, Segment Contribution (%), 2010 27
4.4 Glucose Monitoring Overall Revenue (2003-2017) 28
4.4.1 Blood Glucose Meters Revenue (2003-2017) 32
4.5 Glucose Monitoring Overall Volume (2003-2017) 34
4.5.1 Blood Glucose Meters Volume (2003-2017) 37
4.6 Glucose Monitoring Average Price (2003-2017) 39
4.7 Glucose Monitoring Distribution Share (2009-2010) 40
4.8 Glucose Monitoring, Taiwan, Company share (2009-2010) 41
5 Insulin Delivery In Taiwan 43
5.1 Insulin Delivery, Market Segmentation 43
5.2 Insulin Delivery Market, Taiwan, Revenue Mix ($m), 2010 44

3. 5.3 Insulin Delivery Market, Taiwan, Segment Contribution (%), 2010 45
5.4 Insulin Delivery Overall Revenue (2003-2017) 46
5.4.1 Insulin Pens Revenue (2003-2017) 50
5.4.2 Insulin Pumps Revenue (2003-2017) 54
5.5 Insulin Delivery Overall Volume (2003-2017) 56
5.5.1 Insulin Pens Volume (2003-2017) 59
5.5.2 Insulin Pumps Volume (2003-2017) 63
5.6 Insulin Delivery Average Price (2003-2017) 65
5.7 Insulin Delivery Distribution Share (2009-2010) 66
5.8 Insulin Delivery, Taiwan, Company share (2009-2010) 67
6 Overview of Key Companies in Taiwan Diabetes Care Devices Market 69
6.1 F. Hoffmann-La Roche Ltd. 69
6.1.1 Company Overview 69
6.1.2 Share in the Taiwan Diabetes Care Devices Market 69
6.2 Novo Nordisk A/S 70
6.2.1 Company Overview 70
6.2.2 Share in the Taiwan Diabetes Care Devices Market 70
6.3 LifeScan, Inc. 71
6.3.1 Company Overview 71
6.3.2 Share in the Taiwan Diabetes Care Devices Market 71
6.4 Sanofi 72
6.4.1 Company Overview 72
6.4.2 Share in the Taiwan Diabetes Care Devices Market 72
6.5 Eli Lilly and Company 73
6.5.1 Company Overview 73
6.5.2 Share in the Taiwan Diabetes Care Devices Market 73
6.6 TaiDoc Technology Corporation 74
6.6.1 Company Overview 74
6.6.2 Share in the Taiwan Diabetes Care Devices Market 74
6.7 Apex Biotechnology Corp. 75
6.7.1 Company Overview 75
6.8 Becton, Dickinson and Company 75
6.8.1 Company Overview 75
6.9 Medtronic, Inc. 75
6.9.1 Company Overview 75
6.10 ARKRAY, Inc. 76
6.10.1 Company Overview 76
6.11 Abbott Laboratories 76
6.11.1 Company Overview 76
6.12 Animas Corporation 76

4. 6.12.1 Company Overview 76
6.13 NIPRO CORPORATION 77
6.13.1 Company Overview 77
6.14 BIONIME Corporation 77
6.14.1 Company Overview 77
7 Diabetes Care Devices Market Pipeline Products 78
8 Financial Deals Landscape 81
8.1 Partnerships 81
8.1.1 PositiveID Enters Into Agreement with HMD BioMedical 81
8.1.2 Powder Pharmaceuticals Enters Into An Agreement With Health-Chem Diagnostics 82
8.1.3 ZyXEL Communications Enters Into Strategic Partnership With Entra Health Systems 83
9 Appendix 84
9.1 Definitions of Markets Covered in the Report 85
9.1.1 Diabetes Care Devices 85
9.2 Research Methodology 88
9.3 Secondary Research 88
9.4 Primary Research 89
9.5 Models 89
9.6 Forecasts 90
9.7 Expert Panels 90
9.8 GlobalData Consulting 90
9.9 Currency Conversion 91
9.10 Contact Us 91
9.11 Disclaimer 91
List of Tables
Table 1:Diabetes Care Devices, Taiwan, Overall Revenue ($m), USD Actual, 2003-2017 11
Table 2:Diabetes Care Devices Market, Taiwan, Category Contribution (%), 2010 13
Table 3:Diabetes Care Devices, Taiwan, Cross-Segment Analysis, 2003-2017 15
Table 4:Diabetes Care Devices, Taiwan, Overall Revenue ($m), USD Actual, Historic, 2003-2010
17
Table 5:Diabetes Care Devices, Taiwan, Overall Revenue ($m), USD Actual, Forecast, 2010-2017
19
Table 6:Diabetes Care Devices, Taiwan, Category Volume (Units), 2003-2017 20
Table 7:Diabetes Care Devices, Taiwan, Category Volume (Units), Historic, 2003-2010 21
Table 8:Diabetes Care Devices, Taiwan, Category Volume (Units), Forecast, 2010-2017 22
Table 9:Diabetes Care Devices, Taiwan, Company share by Revenue ($m), USD Actual, 2009-

5. 2010 24
Table 10:Glucose Monitoring Market, Taiwan, Segment Contribution (%), 2010 27
Table 11:Glucose Monitoring, Taiwan, Revenue ($m), USD Actual by Segment, Historic, 2003-
2010 29
Table 12:Glucose Monitoring, Taiwan, Revenue ($m), USD Actual by Segment, Forecast, 2010-
2017 31
Table 13:Blood Glucose Meters (Traditional Glucose Meters), Taiwan, Revenue ($m), USD Actual,
Historic, 2003-2010 32
Table 14:Blood Glucose Meters (Traditional Glucose Meters), Taiwan, Revenue ($m), USD Actual,
Forecast, 2010-2017 33
Table 15:Glucose Monitoring, Taiwan, Volume (Units) by Segment, Historic, 2003-2010 35
Table 16:Glucose Monitoring, Taiwan, Volume (Units) by Segment, Forecast, 2010-2017 36
Table 17:Blood Glucose Meters (Traditional Glucose Meters), Taiwan, Volume (Units), Historic,
2003-2010 37
Table 18:Blood Glucose Meters (Traditional Glucose Meters), Taiwan, Volume (Units), Forecast,
2010-2017 38
Table 19:Glucose Monitoring, Taiwan, Average Price ($), Historic, 2003-2010 39
Table 20:Glucose Monitoring, Taiwan, Average Price ($), Forecast, 2010-2017 39
Table 21:Glucose Monitoring, Taiwan, Distribution Share by Revenue ($m), USD Actual, 2009-
2010 40
Table 22:Glucose Monitoring, Taiwan, Company share by Revenue ($m), USD Actual 2009-2010
42
Table 23:Insulin Delivery Market, Taiwan, Segment Contribution (%), 2010 45
Table 24:Insulin Delivery, Taiwan, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 47
Table 25:Insulin Delivery, Taiwan, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017
49
Table 26:Insulin Pens, Taiwan, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010
51
Table 27:Insulin Pens, Taiwan, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017
53
Table 28:Insulin Pumps (Traditional Insulin Pumps), Taiwan, Revenue ($m), USD Actual, Historic,
2003-2010 54
Table 29:Insulin Pumps (Traditional Insulin Pumps), Taiwan, Revenue ($m), USD Actual,
Forecast, 2010-2017 55
Table 30:Insulin Delivery, Taiwan, Volume (Units) by Segment, Historic, 2003-2010 57
Table 31:Insulin Delivery, Taiwan, Volume (Units) by Segment, Forecast, 2010-2017 58
Table 32:Insulin Pens, Taiwan, Volume (Units) by Sub-Segment, Historic, 2003-2010 60
Table 33:Insulin Pens, Taiwan, Volume (Units) by Sub-Segment, Forecast, 2010-2017 62
Table 34:Insulin Pumps (Traditional Insulin Pumps), Taiwan, Volume (Units), Historic, 2003-2010
63
Table 35:Insulin Pumps (Traditional Insulin Pumps), Taiwan, Volume (Units), Forecast, 2010-2017

6. 64
Table 36:Insulin Delivery, Taiwan, Average Price ($), Historic, 2003-2010 65
Table 37:Insulin Delivery, Taiwan, Average Price ($), Forecast, 2010-2017 65
Table 38:Insulin Delivery, Taiwan, Distribution Share by Revenue ($m), USD Actual, 2009-2010
66
Table 39:Insulin Delivery, Taiwan, Company share by Revenue ($m), USD Actual 2009-2010 68
Table 40:Diabetes Care Devices Market Pipeline Products 78
Table 41:PositiveID Enters Into Agreement With HMD BioMedical 81
Table 42:Powder Pharmaceuticals Enters Into An Agreement With Health-Chem Diagnostics 82
Table 43:ZyXEL Communications Enters Into Strategic Partnership With Entra Health Systems 83
Table 44: USD to Local Currency, Taiwan, Average Actual Rate 2003-2010 91
List of Figures
Figure 1:Diabetes Care Devices, Market Segmentation 10
Figure 2:Diabetes Care Devices, Taiwan, Overall Revenue ($m), USD Actual, 2003-2017 11
Figure 3:Diabetes Care Devices Market, Taiwan, Revenue Mix ($m), 2010 12
Figure 4:Diabetes Care Devices Market, Taiwan, Category Contribution (%), 2010 13
Figure 5:Diabetes Care Devices, Taiwan, Cross-Segment Analysis, 2003-2017 14
Figure 6:Diabetes Care Devices, Taiwan, Overall Revenue ($m), USD Actual, Historic, 2003-2010
16
Figure 7:Diabetes Care Devices, Taiwan, Overall Revenue ($m), USD Actual, Forecast, 2010-
2017 18
Figure 8:Diabetes Care Devices, Taiwan, Category Volume (Units), 2003-2017 20
Figure 9:Diabetes Care Devices, Taiwan, Category Volume (Units), Historic, 2003-2010 21
Figure 10:Diabetes Care Devices, Taiwan, Category Volume (Units), Forecast, 2010-2017 22
Figure 11:Diabetes Care Devices, Taiwan, Company share (%), 2010 23
Figure 12:Glucose Monitoring, Market Segmentation 25
Figure 13:Glucose Monitoring Market, Taiwan, Revenue Mix ($m), 2010 26
Figure 14:Glucose Monitoring Market, Taiwan, Segment Contribution (%), 2010 27
Figure 15:Glucose Monitoring, Taiwan, Revenue ($m), USD Actual by Segment, Historic, 2003-
2010 28
Figure 16:Glucose Monitoring, Taiwan, Revenue ($m), USD Actual by Segment, Forecast, 2010-
2017 30
Figure 17:Blood Glucose Meters (Traditional Glucose Meters), Taiwan, Revenue ($m), USD
Actual, Historic, 2003-2010 32
Figure 18:Blood Glucose Meters (Traditional Glucose Meters), Taiwan, Revenue ($m), USD
Actual, Forecast, 2010-2017 33
Figure 19:Glucose Monitoring, Taiwan, Volume (Units) by Segment, Historic, 2003-2010 34
Figure 20:Glucose Monitoring, Taiwan, Volume (Units) by Segment, Forecast, 2010-2017 36
Figure 21:Blood Glucose Meters (Traditional Glucose Meters), Taiwan, Volume (Units), Historic,

7. 2003-2010 37
Figure 22:Blood Glucose Meters (Traditional Glucose Meters), Taiwan, Volume (Units), Forecast,
2010-2017 38
Figure 23:Glucose Monitoring, Taiwan, Company share (%), 2010 41
Figure 24:Insulin Delivery, Market Segmentation 43
Figure 25:Insulin Delivery Market, Taiwan, Revenue Mix ($m), 2010 44
Figure 26:Insulin Delivery Market, Taiwan, Segment Contribution (%), 2010 45
Figure 27:Insulin Delivery, Taiwan, Revenue ($m), USD Actual by Segment, Historic, 2003-2010
46
Figure 28:Insulin Delivery, Taiwan, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017
48
Figure 29:Insulin Pens, Taiwan, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010
50
Figure 30:Insulin Pens, Taiwan, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-
2017 52
Figure 31:Insulin Pumps (Traditional Insulin Pumps), Taiwan, Revenue ($m), USD Actual, Historic,
2003-2010 54
Figure 32:Insulin Pumps (Traditional Insulin Pumps), Taiwan, Revenue ($m), USD Actual,
Forecast, 2010-2017 55
Figure 33:Insulin Delivery, Taiwan, Volume (Units) by Segment, Historic, 2003-2010 56
Figure 34:Insulin Delivery, Taiwan, Volume (Units) by Segment, Forecast, 2010-2017 58
Figure 35:Insulin Pens, Taiwan, Volume (Units) by Sub-Segment, Historic, 2003-2010 59
Figure 36:Insulin Pens, Taiwan, Volume (Units) by Sub-Segment, Forecast, 2010-2017 61
Figure 37:Insulin Pumps (Traditional Insulin Pumps), Taiwan, Volume (Units), Historic, 2003-2010
63
Figure 38:Insulin Pumps (Traditional Insulin Pumps), Taiwan, Volume (Units), Forecast, 2010-
2017 64
Figure 39:Insulin Delivery, Taiwan, Company share (%), 2010 67
Figure 40:F. Hoffmann-La Roche Ltd., Company Share (%),Taiwan Diabetes Care Devices
Market, 2010 69
Figure 41:Novo Nordisk A/S, Company Share (%),Taiwan Diabetes Care Devices Market, 2010 70
Figure 42:LifeScan, Inc., Company Share (%),Taiwan Diabetes Care Devices Market, 2010 71
Figure 43:Sanofi, Company Share (%),Taiwan Diabetes Care Devices Market, 2010 72
Figure 44:Eli Lilly and Company, Company Share (%),Taiwan Diabetes Care Devices Market,
2010 73
Figure 45:TaiDoc Technology Corporation, Company Share (%),Taiwan Diabetes Care Devices
Market, 2010 74
Contact: sales@reportsandreports.com for more information.